P53 levels determine outcome during β-catenin tumor initiation and metastasis in the mammary gland and male germ cells

Oncogene

Volumn 25, Issue 25, 2006, Pages 3518-3527

  Ridgeway, A G ^a   McMenamin, J ^a   Leder, P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; Metastasis; Oncogene; Teratomas; Tumor suppressor

Indexed keywords

BETA CATENIN; PROTEIN P53;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER INCIDENCE; CONTROLLED STUDY; CROSS BREEDING; FEMALE; GENE ACTIVATION; GENE LOCUS; GENE MUTATION; GERM CELL; HETEROZYGOSITY LOSS; HETEROZYGOTE; KNOCKOUT MOUSE; MALE; METASTASIS; METASTASIS POTENTIAL; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SURVIVAL TIME; TESTIS TERATOMA; TRANSGENIC MOUSE; TUMOR VOLUME; WILD TYPE;

ANIMALS; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LOSS OF HETEROZYGOSITY; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUTATION; PROMOTER REGIONS (GENETICS); RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TERATOMA; TESTICULAR NEOPLASMS;

MOUSE MAMMARY TUMOR VIRUS;

EID: 33745140523     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209391     Document Type: Article

References (51)

1. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R et al. (1998). Science 280: 596-599.
2. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al. (1996). Nature 382: 638-642.
3. Brennan KR, Brown AM. (2004). J Mammary Gland Biol Neoplasia 9: 119-131.
4. Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX. (2001). Oncogene 20: 1445-1454.
5. Brunner E, Peter O, Schweizer L, Basler K. (1997). Nature 385: 829-833.
6. Chung GG, Zerkowski MP, Ocal IT, Dolled-Filhart M, Kang JY, Psyrri A et al. (2004). Cancer 100: 2084-2092.
7. Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J et al. (1999). Embo J 18: 3054-3063.
8. Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A, Oren M. (2001). Embo J 20: 4912-4922.
9. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D et al. (1995a). Genes Dev 9: 882-895.
10. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Nature 356: 215-221.
11. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery Jr CA, Park SH et al. (1995b). Mol Carcinog 14: 16-22.
12. Gunther EJ, Moody SE, Belka GK, Hahn KT, Innocent N, Dugan KD et al. (2003). Genes Dev 17: 488-501.
13. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M et al. (1998). Nucleic Acids Res 26: 205-213.
14. Harris SL, Levine AJ. (2005). Oncogene 24: 2899-2908.
15. Harvey M, McArthur MJ, Montgomery Jr CA, Bradley A, Donehower LA. (1993). Faseb J 7: 938-943.
16. Hatsell S, Rowlands T, Hiremath M, Cowin P. (2003). J Mammary Gland Biol Neoplasia 8: 145-158.
17. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Science 281: 1509-1512.
18. Henrard D, Ross SR. (1988). J Virol 62: 3046-3049.
19. Honecker F, Kersemaekers AM, Molier M, Van Weeren PC, Stoop H, De Krijger RR et al. (2004). J Pathol 204: 167-174.
20. Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Subler MA, Windle JJ. (1997). Mol Cell Biol 17: 723-731.
21. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. (1998). Embo J 17: 1371-1384.
22. Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P. (2001). J Cell Biol 153: 555-568.
23. Jones JM, Attardi L, Godley LA, Laucirica R, Medina D, Jacks T et al. (1997). Cell Growth Differ 8: 829-838.
24. Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, van Leeuwen S et al. (2002). Nat Genet 32: 594-605.
25. Kinzler KW, Vogelstein B. (1996). Cell 87: 159-170.
26. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S et al. (1998). J Biol Chem 273: 10823-10826.
27. Kozma S, Osterrieth PM, Francois C, Calbere-Bacq CM. (1980). J Gen Virol 51: 327-339.
28. Levina E, Oren M, Ben-Ze'ev A. (2004). Oncogene 23: 4444-4453.
29. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X et al. (2003). Proc Natl Acad Sci USA 100: 15853-15858.
30. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y et al. (2000). Proc Natl Acad Sci USA 97: 4262-4266.
31. Liu BY, McDermott SP, Khwaja SS, Alexander CM. (2004). Proc Natl Acad Sci USA 101: 4158-4163.
32. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL et al. (2001). Mol Cell 7: 927-936.
33. Martin SS, Ridgeway AG, Pinkas J, Lu Y, Reginato MJ, Koh EY et al. (2004). Oncogene 23: 4641-4645.
34. Matsuzawa SI, Reed JC. (2001). Mol Cell 7: 915-926.
35. Michaelson JS, Leder P. (2001). Oncogene 20: 5093-5099.
36. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V et al. (1996). Cell 86: 391-399.
37. Polakis P. (2000). Genes Dev 14: 1837-1851.
38. Rodriguez I, Ody C, Araki K, Garcia I, Vassalli P. (1997). Embo J 16: 2262-2270.
39. Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP. (2001). Nat Cell Biol 3: 793-801.
40. Sadot E, Geiger B, Oren M, Ben-Ze'ev A. (2001). Mol Cell Biol 21: 6768-6781.
41. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. (2004). Nat Med 10: 55-63.
42. Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW. (2002). Cancer Cell 1: 289-298.
43. Slee EA, O'Connor DJ, Lu X. (2004). Oncogene 23: 2809-2818.
44. Smalley MJ, Dale TC. (2001). J Mammary Gland Biol Neoplasia 6: 37-52.
45. Stevens LC. (1967). J Natl Cancer Inst 38: 549-552.
46. Stevens LC, Mackensen JA. (1961). J Natl Cancer Inst 27: 443-453.
47. Tetsu O, McCormick F. (1999). Nature 398: 422-426.
48. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J et al. (1997). Cell 88: 789-799.
49. Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D et al. (1998). Embo J 17: 4657-4667.
50. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T et al. (2003). Nature 423: 448-452.
51. Yin Y, Stahl BC, DeWolf WC, Morgentaler A. (1998). Dev Biol 204: 165-171.